Navigation Links
Use of MarginProbe® in DCIS Patients Presented at San Antonio Breast Cancer Symposium
Date:12/8/2011

FRAMINGHAM, Mass., Dec. 8, 2011 /PRNewswire/ -- An analysis of the MarginProbe pivotal study for patients with ductal carcinoma in situ (DCIS) and invasive lobular carcinoma (ILC) were presented today during the 2011 CTRC-AACR San Antonio Breast Cancer Symposium.  The results were presented by Dr. Susan K. Boolbol, Chief, Division of Breast Surgery, Beth Israel Medical Center, New York, New York.  In patients with DCIS or ILC, adjunctive use of MarginProbe significantly improved surgical outcomes by increasing surgeons' ability to identify and immediately resect positive margins, reducing the number of patients requiring re-excision by 49% and 64% respectively.

"DCIS and ILC represent a particular challenge to the breast surgeon," said Dr. Boolbol.  "Current intraoperative techniques are sub-optimal, leading to re-excision rates as high as 40%, as reported in the literature.  These study results represent a tremendous opportunity for breast surgeons to improve the quality of care they offer their patients."

"These results further reinforce the evidence of MarginProbe's benefit in all disease types, including the most challenging DCIS and lobular cases.  These results mirror those seen in Germany in our post-market study," said Dan Levangie, CEO of Dune Medical Devices.  "Across multiple studies, in the U.S., Europe, and Israel, adjunctive use of MarginProbe has consistently led to a 50% reduction in the number of patients requiring re-excision surgery in all disease types."

About the MarginProbe System

The MarginProbe System enables real time detection of cancer at or near the surface of excised tissue specimens during surgery for breast cancer.  The simple and immediate assessment of the surgical margins allows surgeons to immediately excise additional tissue, potentially saving a second procedure.  The MarginProbe System is Dune's first commercial product and is commercially availa
'/>"/>

SOURCE Dune Medical Devices
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. MarginProbe® Pivotal Study Presented at San Antonio Breast Cancer Symposium
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. Many Heart Attack Patients Dont Get Best Emergency Treatment
10. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
11. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015  Rigrodsky & Long, P.A.: ... Inc. (NASDAQ GM: AERI )? , Did you purchase ... , Did you lose money in your investment in Aerie ... Rigrodsky & Long, P.A. , including ... announces that a complaint has been filed in the United States ...
(Date:5/6/2015)... South Africa , May 6, 2015 ... than HIV/AIDS, malaria and tuberculosis combined[1]. Approximately 40 percent of ... cured with the right treatment[3]. Together with Elekta, ministries of ... build up their radiation therapy infrastructures and save lives. ... would benefit from radiation therapy[4] during the course of their ...
(Date:5/6/2015)... Markets ( http://www.researchandmarkets.com/research/jskhnb/energy_based ) has announced the addition ... Business Report" report to their offering. The ... Canada , Japan , ... of World. Annual estimates and forecasts are provided for the ... provided for these markets. The global market is ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 3Elekta to bring cancer treatment to millions in Africa 2Elekta to bring cancer treatment to millions in Africa 3Elekta to bring cancer treatment to millions in Africa 4Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3
(Date:5/6/2015)... Chesapeake Regional Medical Center is the ... acquire Intuitive Surgical, Inc.’s latest model of the ... enhanced surgical technique capabilities, which can be used ... spectrum of specialties. Its advancements allow patients less ... times. , “As the only independent, community-based hospital ...
(Date:5/6/2015)... May 06, 2015 The Beryl Institute ... of Patient Experience Journal (PXJ), an international, open ... around understanding and improving patient experience. The second volume ... experience conversation globally, helps align the voices engaged and ... , Published in association with The Beryl Institute, Volume ...
(Date:5/6/2015)... 06, 2015 Is Colorado’s legal cannabis ... month the Centennial State will mark the 18-month milestone ... to adults. And while Colorado’s legal marijuana industry has ... time, it’s also facing some new challenges. , For ... facing shortages, especially in the wake of last month’s ...
(Date:5/6/2015)... vcfo, a specialized consulting firm that provides ... to optimize business performance and productivity, announced the additions ... Scheaffer. Both Lynch and Scheaffer have more than 25 ... “We are delighted to add Jack and Mike to ... background in financial management and leadership, Mike and Jack ...
(Date:5/6/2015)... Anitoa Systems, (“Anitoa”), a Palo Alto startup ... China, has successfully demonstrated a handheld real time quantitative-polymerase-chain-reaction ... Anitoa’s handheld qPCR is shown to be capable of ... hepatitis B, C, and E. Coli. This qPCR system ... and over 9 orders of magnitude dynamic range. ...
Breaking Medicine News(10 mins):Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3Health News:vcfo Adds Two Senior Executives to Growing Team 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3
... is so much alike the code of humans, almost a ... And yet, // there are glaring differences, despite the 98% ... not a different set of genes that caused the difference, ... According to a latest theory on evolution, even small alterations ...
... many are not aware of the Medicare part D program’s guidelines. ... Roxbury Presbyterian Church was a great relief for them. ... the bus, which has been traversing New England cities and towns ... , The deadline to sign up for new prescription drug coverage ...
... Women with disproportionate or uneven breasts have a greater likelihood ... record any alterations or changes in the breast, the study ... conducted a study where mammograms of 252 women who developed ... healthy women. It was observed that, though breast cancer ...
... psychiatrist Dr Charles Reynolds at the University of Pittsburgh which ... , The study’s main aim was to analyze the ... people. It is one of the longest studies ever ... antidepressants for longer periods, perhaps even for life, in patients ...
... nominated to run the U.S. Food and Drug Administration, ... pressure while scientific decisions were being made//. He further ... medical endeavors, the appropriateness should also be taken into ... the FDA and Director of National Cancer Institute, would ...
... years old and two adults were placed under quarantine in ... part of Maharashtra. ,Tina Nanavade from Rawer taluka, ... was admitted to Nhavi Hospital on Sunday afternoon. Tami flu ... a possible bird-flu. ,Sarla More from Jamner, a ...
Cached Medicine News:Health News:Drugs Are Effective In Treating Depression and Preventing Recurrence 2Health News:FDA Nominee Says That He Is Not Influenced By Politics 2
... volume laboratories, as well as specialty labs, ... simplicity and flexibility needed to respond to ... Elecsys 1010 system enables operators to handle ... testing without sacrificing ease of operation or ...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
... System provides high-performance detection technologies to ... and therapeutic drugs. It also delivers ... that allow the laboratory to streamline ... This high-productivity design enables numerous functions ...
The Embla 384 cell washer is a top-loading, robotic-compatible microplate washer for high throughput screening. It is designed specifically for cell-based assays, which require a gentler wash, but ca...
Medicine Products: